论文部分内容阅读
作为有国际大牌投资机构傍身的诺康生物,其上市是意料之中的事。但是,其上市首日即跌近4%,却有些意料之外。诺康生物是设立在沈阳浑南开发区的一家从事心血管和血液学领域的生物活性酶类和自源性高效激活因子药物的研发和生产公司。2008年初,红杉资本中国基金联合HBM生物基金向诺康生物投入了1700万美元。红杉资本中国基金创始及
As a nongkang creature with international big investment institutes, its listing is a surprise. However, it was somewhat unexpected when its listing fell nearly 4% on the first day of listing. Nuokang Bio is a R & D and manufacturing company of bioactive enzymes and self-derived high-potency activators in the cardiovascular and hematology field in Hunnan Development Zone, Shenyang. At the beginning of 2008, Sequoia Capital China Fund and HBM Biological Fund invested $ 17 million into Noc Bio. Founding of Sequoia Capital China Fund and